Efficacy and safety of immunotherapies for the treatment of Alzheimer’s disease: A network meta-analysis

Author : Rida Rabab Chowdhury, Igor Nikolayevich Iezhitsa

Abstract :Background: Alzheimer’s disease (AD) is a progressive neurogenerative disorder regarded as the most prevalent cause of dementia, particularly amongst the aging population. AD contributes to 60 70% of cases with there being over 10 million new cases of dementia each year worldwide. Unfortunately, currently, available treatments for AD can only limit the symptoms of cognitive impairment. Due to this, the focus for AD treatment incorporates addressing, limiting and potentially halting the pathogenesis of amyloid-beta (Aβ) and the accumulation of abnormal tau protein in the brain, altogether. However, the safety and efficacy of this treatment regime must be collated to ensure its clinical use in improving the livelihood of AD patients.

Keywords :Alzheimer’s Disease, Dementia, Amyloid-Beta, Tau Protein, Neurodegeneration, Treatment Approaches

Conference Name :World Heart and Brain Conference (WHBC-25)

Conference Place Melbourne, Australia

Conference Date 6th Aug 2025